Apparently FDA approval, and sales progress in company with consent is worthless.
this downward trend is now beginning to price in total financial / operating failure.
a drug flaw would be catastrophic and we know it’s not that.
does anyone really believe this is not selling and we are about to suffer consequences of extreme fiscal mismanagement?
if not - what tf is going on?
Add to My Watchlist
What is My Watchlist?
